| 000 | 01338 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511181435.0 | ||
| 264 | 0 | _c19921216 | |
| 008 | 199212s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbel, P W | |
| 245 | 0 | 0 |
_aCharacterization of beta-adrenergic receptors in DiFi and HT-29 cells. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a1655-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
| 650 | 0 | 4 |
_aAdenomatous Polyposis Coli _xmetabolism |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aAtenolol _xpharmacology |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aColonic Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIodocyanopindolol |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMetoprolol _xpharmacology |
| 650 | 0 | 4 |
_aPindolol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPropanolamines _xpharmacology |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta _xdrug effects |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aZeng, W | |
| 700 | 1 | _aWildrick, D M | |
| 700 | 1 | _aMakoid, M C | |
| 700 | 1 | _aBoman, B M | |
| 773 | 0 |
_tAnticancer research _gvol. 12 _gno. 5 _gp. 1655-8 |
|
| 999 |
_c1366338 _d1366338 |
||